Hong Kong targets biomedicine powerhouse status in debut five-year plan

Biomedicine is set to feature in Hong Kong’s first five-year plan, due to be unveiled next week, as the city’s top officials signal closer medical cooperation across the Greater Bay Area. Lending weight to those ambitions, global pharmaceutical company GSK emphasised its interest in expanding its ro

HK24H 僅展示標題與短摘要，全文版權歸 SCMP Business 所有。